scispace - formally typeset
S

Shiping Hu

Researcher at Third Military Medical University

Publications -  5
Citations -  103

Shiping Hu is an academic researcher from Third Military Medical University. The author has contributed to research in topics: Gut flora & Colitis. The author has an hindex of 1, co-authored 5 publications receiving 6 citations.

Papers
More filters
Journal ArticleDOI

Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration

TL;DR: In this article, the authors investigated the interplay between heparanase and the gut microbiota in the development of acute pancreatitis and found that the commensal Parabacteroides contributed most to distinguish the differences between wild-type and heparanase-transgenic mice.
Journal ArticleDOI

Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease.

TL;DR: An overview of the cross-talk between the gut microbiota and the lungs is provided to elucidate the underlying pathogenesis and/or potential therapeutic strategies of some lung diseases from the point of view of the Gut microbiota.
Journal ArticleDOI

Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner

TL;DR: In this article, a colitis model was constructed by continuously administering 2.5% dextran sodium sulfate (DSS) solution daily for 7 days, and the therapeutic function of LC against colitis and investigate the mechanism of intestinal flora and metabolism modulation.
Journal ArticleDOI

Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis.

TL;DR: In this article, the authors reported that H. pylori infection promotes up-regulation of heparanase in gastritis, which in turn facilitates the colonization of H.pylori in the gastric mucosa, thereby aggravating gastritis.
Journal ArticleDOI

Lithium Carbonate Treatment Alleviates Gut Inflammation Through Activating Treg Cell Responses in a Microbiota-Dependent Manner

TL;DR: The role of LC as a potential regulator of intestinal flora in the prevention and treatment of gut inflammation is demonstrated and provides a new strategy for the treatment of ulcerative colitis or IBD.